Publicaciones en colaboración con investigadores/as de University of Texas Southwestern Medical Center (16)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

2023

  1. Long non-coding RNAs: definitions, functions, challenges and recommendations

    Nature Reviews Molecular Cell Biology, Vol. 24, Núm. 6, pp. 430-447

2021

  1. Elevated NSD3 histone methylation activity drives squamous cell lung cancer

    Nature, Vol. 590, Núm. 7846, pp. 504-508

  2. Galectin-3 Inhibition With Modified Citrus Pectin in Hypertension

    JACC: Basic to Translational Science, Vol. 6, Núm. 1, pp. 12-21

2020

  1. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

    Journal for ImmunoTherapy of Cancer, Vol. 8, Núm. 1

2019

  1. A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets

    Journal of Hepatology, Vol. 71, Núm. 1, pp. 78-90

2018

  1. Basic and Translational Advances in Glioblastoma

    BioMed Research International

  2. Perspectives in immunotherapy: Meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy)

    Journal for ImmunoTherapy of Cancer, Vol. 6, Núm. 1

  3. The IASLC Lung Cancer Staging Project: A Renewed Call to Participation

    Journal of Thoracic Oncology, Vol. 13, Núm. 6, pp. 801-809

2016

  1. Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting

    Cytometry Part B - Clinical Cytometry, Vol. 90, Núm. 1, pp. 31-39

  2. Perspectives in immunotherapy: Meeting report from the "Immunotherapy Bridge", Napoli, December 5th 2015

    Journal for ImmunoTherapy of Cancer, Vol. 4, Núm. 1

2009

  1. A gene-alteration profile of human lung cancer cell lines

    Human Mutation, Vol. 30, Núm. 8, pp. 1199-1206

2006

  1. ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemia

    Oncogene, Vol. 25, Núm. 13, pp. 1862-1870

  2. Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia

    International Journal of Cancer, Vol. 118, Núm. 8, pp. 1945-1953

2005

  1. Expression of transcription factor E2F1 and telomerase in glioblastomas: Mechanistic linkage and prognostic significance

    Journal of the National Cancer Institute, Vol. 97, Núm. 21, pp. 1589-1600